Cardiac Ablation Devices Market is segmented By Technology (Radiofrequency Ablation, Electrical Ablation, Cryoablation, Ultrasound Ablation, Microwave....
Market Size in USD
CAGR12.4%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 12.4% |
Market Concentration | High |
Major Players | Abbott Laboratories, Boston Scientific Corporation, Medtronic plc., Biosense Webster, Inc., AtriCure, Inc. |
The cardiac ablation devices market is estimated to be valued at USD 2.53 Billion in 2024 and is expected to reach USD 5.11 Billion by 2031, growing at a compound annual growth rate (CAGR) of 12.4% from 2024 to 2031. The increasing prevalence of cardiac arrhythmias and the growing demand for minimally invasive procedures are fueling market growth. Key players are investing in the development of irrigated-tip catheters, cryoablation, laser and ultrasound ablation technologies to improve efficacy and reduce risks associated with procedures.